Ajanta Pharma Ltd — Quarterly Results & Earnings

₹2805.10

-2.50%

Profit Growth YoY20.19%Latest quarter

Sales Growth YoY14.08%Latest quarter

Sales CAGR 5Y12.43%5 year compound

Profit CAGR 5Y14.26%5 year compound

📋

Quarterly Performance

YoY Profit Growth+20.19%

🔥 Exceptional growth

YoY Sales Growth+14.08%

✅ Strong growth

OPM 5Y Average

Operating profit margin

27.53%

EPS Growth 5Y

15.34%

Interest Coverage

Higher = safer debt servicing

56.18

ROE

24.91%

ROCE

32.37%

💡

Growth Analysis

Ajanta Pharma Ltd reported YoY profit growth of 20.19% and revenue growth of 14.08% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 12.43% and profits at 14.26% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Ajanta Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.